Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Astrazeneca Pharma India Limited
Astrazeneca Pharma India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:506820NSE:ASTRAZENBloomberg:ASTR@INReuters:ASTR.BO
Market Lot: 1Face Value: 2ISIN Demat: INE203A01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
28-APR-14 Pfizer Inc. confirms that it previously submitted a preliminary, non-binding indication of interest to the board of directors of AstraZeneca Pharma in January 2014 regarding a possible merger transaction. In light of recent market developments, 20-DEC-13 AstraZeneca today announced an agreement under which AstraZeneca will acquire the entirety of Bristol-Myers Squibb's interests in the companies' diabetes alliance for an initial con...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
AstraZeneca Pharma gains on delisting proposal  -IRIS 23-Jun-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1255.734737.483902.54
Other Income17.9392.08104.63
Total Income1273.664829.564007.17
Cost of goods sold1416.074869.434588.76
OPBDIT-142.41-39.87-581.59
PAT-176.00-5.09-895.32
Gross Block---
Equity capital50.0050.0050.00
EPS (Rs.)--0.20-35.81
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI)-11.2-0.8-14.5
Net margin (% of OI)-13.8-0.1-22.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Avishkar
Off Bellary Road
Hebbal
Bangalore
Karnataka-560 024
PHONE
(080) 2362 2021-27
FAX
(080) 2362 2015
 
Board of Directors
Board Meetings
Date Purpose
03-NOV-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer